Our lab specializes in advanced stem cell research, combining cellular reprogramming, organoid development, genome engineering, and high-throughput sequencing. Here's an overview of our core activities:
Reprogramming and iPSC Generation
We reprogram somatic cells from easily accessible sources like skin or urine into induced pluripotent stem cells (iPSCs). This process involves introducing specific (Yamanaka) factors (OCT4, SOX2, KLF, C-MYC) to reset the cells to a stem-like state.
iPSC Quality Control
We thoroughly characterize our iPSCs to ensure their quality and pluripotency:
Cell Differentiation
Genome Engineering
We use cutting-edge CRISPR technology for precise genetic modifications:
Sequencing and Analysis (The lab is equipped with Illumina, Nanopore and PacBio Sequencers)
Our comprehensive sequencing capabilities include:
By integrating these technologies, we study human development and aging, model aging and aging-associated diseases, and explore potential new therapeutic and preventive strategies. Our work contributes to advancements in personalized medicine, drug discovery, and regenerative medicine.
Head of GEMD:
Andrea Rossi
We have developed the following software to facilitate bioinformatic analysis in the lab:
Scientists
Postdocs
PhD student
Master student
Technical assistance
IUF – Leibniz-Institut für umwelt-
medizinische Forschung GmbH
Auf'm Hennekamp 50
40225 Düsseldorf
Postfach 10 30 45
40021 Düsseldorf
Telefon: +49- (0)211-3389-0
Telefax: +49- (0)211-3190910
IUF – Leibniz-Institut für umwelt-
medizinische Forschung GmbH
Auf'm Hennekamp 50
40225 Düsseldorf
Postfach 10 30 45
40021 Düsseldorf
Telefon: +49- (0)211-3389-0
Telefax: +49- (0)211-3190910